| Cash Flow | 2025-10-31 | 2025-07-31 | 2025-04-30 | 2024-10-31 |
|---|---|---|---|---|
| Revenue | - | - | 356,624 | - |
| Adjusted cost of revenue-License | - | - | 1,028 | - |
| Adjusted cost of revenue-Subscription Services | - | - | 33,385 | - |
| Adjusted cost of revenue-Professional Services And Other | - | - | 21,366 | - |
| Adjusted sales and marketing | - | - | 133,191 | - |
| Adjusted research and development | - | - | 60,185 | - |
| Adjusted general and administrative | - | - | 37,853 | - |
| Other segment items | - | - | 100,584 | - |
| Amortization of acquired intangible assets | - | - | 1,408 | - |
| Interest income | - | - | 12,648 | - |
| Provision for income taxes | - | - | 2,827 | - |
| Net income (loss) | 177,868 | -20,971 | -22,555 | -125,488 |
| Depreciation and amortization | 11,996 | 7,483 | 3,253 | 14,017 |
| Amortization of deferred contract acquisition costs | 71,096 | 44,165 | 21,324 | 62,951 |
| Net accretion on marketable securities | 9,047 | 6,962 | 3,630 | 26,552 |
| Stock-based compensation expense | 225,842 | 154,367 | 76,361 | 270,520 |
| Charitable donation of class a common stock | 4,187 | 4,187 | 4,187 | 6,564 |
| Non-cash operating lease expense | 12,904 | 8,691 | 3,377 | 11,762 |
| Benefit from deferred income taxes | -187,310 | -360 | 640 | -20,773 |
| Credit loss expense | 4,591 | - | - | - |
| Other non-cash charges (credits), net | -6,137 | -3,940 | -12,704 | 57 |
| Accounts receivable | -93,457 | -192,404 | -197,443 | -98,062 |
| Contract assets | 37,146 | 23,514 | 9,460 | 32,179 |
| Deferred contract acquisition costs | 65,617 | 36,302 | 13,954 | 59,657 |
| Prepaid expenses and other assets | 10,378 | 21,151 | 13,074 | -10,228 |
| Accounts payable | -17,401 | -11,706 | -15,025 | 14,954 |
| Accrued expenses and other liabilities | 36,027 | 37,841 | 12,352 | 11,230 |
| Accrued compensation and employee benefits | -28,846 | -51,354 | -72,534 | -48,587 |
| Operating lease liabilities, net | -7,452 | -6,412 | -2,146 | -10,750 |
| Deferred revenue | -92,048 | -113,757 | -60,261 | -1,762 |
| Net cash provided by operating activities | 188,860 | 160,589 | 119,002 | 174,483 |
| Purchases of marketable securities | 507,239 | 300,059 | 153,353 | 1,162,243 |
| Maturities of marketable securities | 585,081 | 257,134 | 111,083 | 1,176,776 |
| Purchases of property and equipment | 15,996 | 12,832 | 12,832 | 7,531 |
| Payments related to business acquisition, net of cash acquired | 24,821 | 24,821 | 24,821 | - |
| Purchases of investments | - | 0 | - | 35,809 |
| Other investing, net | 16,839 | - | - | 0 |
| Net cash provided by (used in) investing activities | 20,186 | -80,578 | -79,923 | -28,807 |
| Repurchases of class a common stock | 329,101 | 329,101 | 227,525 | 381,403 |
| Proceeds from exercise of stock options | 967 | 523 | 302 | 934 |
| Payments of tax withholdings on settlement of equity awards | 41,703 | 26,278 | 12,195 | 60,483 |
| Net (payments) receipts of tax withholdings on sell-to-cover equity award transactions | - | -19 | - | 99 |
| Proceeds from employee stock purchase plan contributions | 11,864 | 8,069 | 4,214 | 12,893 |
| Payment of deferred consideration related to business acquisition | 0 | 0 | - | 5,570 |
| Net cash used in financing activities | -357,973 | -346,806 | -235,204 | -433,530 |
| Effect of exchange rate changes | 13,391 | 16,216 | 17,570 | -194 |
| Net decrease in cash, cash equivalents, and restricted cash | -135,536 | -250,579 | -178,555 | -288,048 |
| Cash and cash equivalents at beginning of period | 879,634 | 879,634 | 879,634 | 1,062,116 |
| Cash and cash equivalents at end of period | 744,098 | 629,055 | 701,079 | 774,068 |
UiPath, Inc. (PATH)
UiPath, Inc. (PATH)